4//SEC Filing
PELUSO MICHELLE A 4
Accession 0001127602-23-003336
CIK 0000064803other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:32 PM ET
Size
8.5 KB
Accession
0001127602-23-003336
Insider Transaction Report
Form 4
PELUSO MICHELLE A
EVP and Co-President of Retail
Transactions
- Award
Common Stock
2023-02-02+192,554→ 207,465 total
Holdings
- 82,563
Common Stock (restricted)
- 86,386
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (86,386 underlying) - 57,172
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (57,172 underlying)
Footnotes (4)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 26, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 2, 2023.
- [F2]Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
- [F3]Option became exercisable in four equal annual installments, commencing 4/1/2022.
- [F4]Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001271739
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:32 PM ET
- Size
- 8.5 KB